DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Packer RJ, Jakacki R, Horn M. et al.
Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan.
Pediatric blood & cancer 2009;
52: 791-795
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.